The role of GAPDH acetylation and HDAC6 in liver metabolism and type 2 diabetes [ 2017 - 2019 ]

Research Grant

Researchers: A/Pr Sean Mcgee (Principal investigator) ,  A/Pr Clinton Bruce ,  Prof Ken Walder

Brief description Type 2 diabetes (T2D) is characterised by persistent elevated blood glucose levels. Altered liver metabolism is a key contributor to elevated blood glucose levels in T2D, through uncontrolled synthesis and release of glucose. This project will examine whether regulation of a metabolic enzyme called GAPDH by a process termed acetylation, contributes to normal liver glucose metabolism. This project will also assess whether altered GAPDH acetylation contributes to hyperglycaemia in T2D.

Funding Amount $AUD 650,975.43

Funding Scheme Project Grants

Notes Standard Project Grant